Consistent with previous observations in melanoma cells and human microvascular endothelial cells [47], [48], [49], we demonstrated that cell proliferation was potently downregulated in HSA/TIMP-2-treated tumor tissue as well as HUVECs. Here, TIMP2 is linked to neoplasm.